Wang Feilong, Pan Wenzhi, Wang Hairong, Zhou Yu, Wang Shuyun, Pan Shuming
Crit Care. 2014 Jan 9;18(1):R9. doi: 10.1186/cc13186.
Cystatin C (Cysc) could be affected by thyroid function both in vivo and in vitro and thereby may have limited ability to reflect renal function. We aimed to assess the association between Cysc and thyroid hormones as well as the effect of thyroid function on the diagnostic accuracy of Cysc to detect acute kidney injury (AKI).
A total of 446 consecutive intensive care unit (ICU) patients were screened for eligibility in this prospective AKI observational study. Serum Cysc, thyroid hormones and serum creatinine (Scr) were measured upon entry to the ICU. We also collected each patient's baseline characteristics including the Acute Physiology and Chronic Health Evaluation II (APACHE-II) score. The diagnostic performance of Cysc was assessed from the area under the receiver operator characteristic curve (AUC) in each quartile of thyroid hormone(s).
A total of 114 (25.6%) patients had a clinical diagnosis of AKI upon entry to the ICU. The range of free thyroxine (FT4) value was 4.77 to 39.57 pmol/L. Multivariate linear regression showed that age (standardized beta = 0.128, P < 0.0001), baseline Scr level (standardized beta = 0.290, P < 0.0001), current Scr (standardized beta = 0.453, P < 0.0001), albumin (standardized beta = -0.086, P = 0.006), and FT4 (standardized beta = 0.062, P = 0.039) were related with Cysc. Patients were divided into four quartiles based on FT4 levels. The AUC for Cysc in detecting AKI in each quartile were as follows: 0.712 in quartile I, 0.754 in quartile II, 0.829 in quartile III and 0.797 in quartile IV. There was no significant difference in the AUC between any two groups (all P > 0.05). The optimal cut-off value of Cysc for diagnosing AKI increased across FT4 quartiles (1.15 mg/L in quartile I, 1.15 mg/L in quartile II, 1.35 mg/L in quartile III and 1.45 mg/L in quartile IV).
There was no significant impact of thyroid function on the diagnostic accuracy of Cysc to detect AKI in ICU patients. However, the optimal cut-off value of Cysc to detect AKI could be affected by thyroid function.
胱抑素C(Cysc)在体内和体外均可受甲状腺功能影响,因此其反映肾功能的能力可能有限。我们旨在评估Cysc与甲状腺激素之间的关联,以及甲状腺功能对Cysc检测急性肾损伤(AKI)诊断准确性的影响。
在这项前瞻性AKI观察性研究中,共筛选了446例连续入住重症监护病房(ICU)的患者是否符合条件。入住ICU时测定血清Cysc、甲状腺激素和血清肌酐(Scr)。我们还收集了每位患者的基线特征,包括急性生理与慢性健康状况评分系统II(APACHE-II)评分。根据甲状腺激素各四分位数下的受试者工作特征曲线(ROC)下面积(AUC)评估Cysc的诊断性能。
共有114例(25.6%)患者在入住ICU时被临床诊断为AKI。游离甲状腺素(FT4)值范围为4.77至39.57 pmol/L。多变量线性回归显示,年龄(标准化β=0.128,P<0.0001)、基线Scr水平(标准化β=0.290,P<0.0001)、当前Scr(标准化β=0.453,P<0.0001)、白蛋白(标准化β=-0.086,P=0.006)和FT4(标准化β=0.062,P=0.039)与Cysc相关。根据FT4水平将患者分为四个四分位数。各四分位数中Cysc检测AKI的AUC如下:第一四分位数为0.712,第二四分位数为0.754,第三四分位数为0.829,第四四分位数为0.797。任意两组之间的AUC均无显著差异(所有P>0.05)。诊断AKI的Cysc最佳截断值在FT4四分位数间升高(第一四分位数为1.15 mg/L,第二四分位数为1.15 mg/L,第三四分位数为1.35 mg/L,第四四分位数为1.45 mg/L)。
甲状腺功能对ICU患者中Cysc检测AKI的诊断准确性无显著影响。然而,检测AKI的Cysc最佳截断值可能受甲状腺功能影响。